BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8250731)

  • 1. [Serum levels of soluble CD25 (soluble interleukin 2 receptor) in asthmatic patients].
    Shiota Y; Sato T; Ono T
    Arerugi; 1993 Aug; 42(8):914-9. PubMed ID: 8250731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum soluble CD23 and soluble CD25 in bronchial asthmatic patients].
    Shiota Y; Sato T; Ono T; Kaji M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Aug; 31(8):932-5. PubMed ID: 8230890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum levels of soluble ICAM-1 in asthmatic patients].
    Shiota Y; Sato T; Ono T
    Arerugi; 1993 Dec; 42(12):1782-7. PubMed ID: 7906509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor in sputum from patients with bronchial asthma.
    Motojima S; Ogata H; Tateishi K; Kushima A; Yamai T; Fukuda T; Makino S
    Arerugi; 1993 Feb; 42(2):162-6. PubMed ID: 8507158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression.
    Bogner MP; Voss SD; Bechhofer R; Hank JA; Roper M; Poplack D; Hammond D; Sondel PM
    J Immunother (1991); 1992 Feb; 11(2):111-8. PubMed ID: 1571333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation of T lymphocyte subsets in asthma patients in clinical remission and molecular mechanism thereof].
    Feng MJ; Qiu C; Chen CX; Li FR
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1594-8. PubMed ID: 17803846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
    Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin 2 receptors in patients with Bell's palsy.
    Bujía J; Kim C; Bruegel F
    Allergol Immunopathol (Madr); 1996; 24(3):112-5. PubMed ID: 8766741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission.
    Pumputiene I; Emuzyte R; Dubakiene R; Firantiene R; Tamosiunas V
    Allergy; 2006 Jan; 61(1):43-8. PubMed ID: 16364155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls.
    Hoeger PH; Niggemann B; Ganschow R; Dammann C; Haeuser G
    Allergy; 1994 Apr; 49(4):217-21. PubMed ID: 8037354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
    Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW
    Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-resistant asthma immunologic characteristics.
    Sun Y; Luo W
    Chin Med J (Engl); 1996 Jul; 109(7):527-32. PubMed ID: 9206099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD86 protein in serum samples of patients with asthma.
    Shi HZ; Xie ZF; Deng JM; Chen YQ; Xiao CQ
    Thorax; 2004 Oct; 59(10):870-5. PubMed ID: 15454653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble serum interleukin 2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis.
    Brown JE; Greenberger PA; Yarnold PR
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):484-8. PubMed ID: 7788514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis.
    Hol BE; Hintzen RQ; Van Lier RA; Alberts C; Out TA; Jansen HM
    Am Rev Respir Dis; 1993 Sep; 148(3):643-9. PubMed ID: 8396372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imbalanced T cell-specific transcription factors T-bet and GATA-3 contributes to type 2 T helper cell polarization in asthmatic patients].
    Liu CT; Wang G; Luo FM; Wang ZL; Liu R; Wang CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):398-402. PubMed ID: 15256090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.